Valeant Pharmaceuticals turned a second-quarter profit, as acquisitions and sales from emerging markets helped to counter a jump in some expenses.

The Canadian company also raised its 2013 earnings forecast.

Valeant earned $10.9 million, or 3 cents per share, in the three months that ended June 30. That compares to a loss of $21.6 million, or 7 cents per share, in last year's quarter.

Total revenue climbed 34 percent to $1.1 billion, and adjusted earnings totaled $1.34 per share.

Analysts expected, on average, earnings of $1.28 per share on $1.09 billion in revenue, according to FactSet.

The company said its revenue would have climbed 41 percent compared with last year, if a one-time $45 million drug-launch payment it received in the 2012 quarter is excluded.

In this year's quarter, Valeant's revenue from developed markets rose 37 percent to $792 million, led by contributions from acquisitions. Emerging markets revenue jumped 26 percent to $304 million, as the drugmaker saw strong growth in Poland, Russia, Brazil and Mexico, among other countries.

Those gains were balanced in part by a 39-percent increase in selling, general and administrative expenses, which climbed to $257.4 million.

Valeant said it now expects 2013 earnings to range between $6 and $6.20, up from its previous forecast for between $5.55 and $5.85 per share.

Analysts expect, on average, earnings of $5.89 per share.

U. S.-traded shares of Valeant Pharmaceuticals International Inc. closed at $95.72 on Tuesday. The stock has climbed about 60 percent so far this year after closing 2012 at $59.77.


Publishing Services International Limited (PSIL) is the publisher and operator of a worldwide network of online news sites dedicated to delivering fair, accurate and relevant reporting from a variety of the world’s most trusted sources – from the biggest cities to the smallest towns.

We deliver positive and powerful messages to our readers, providing up‑to‑the‑second news that matters to the individual.

Our promise is to serve communities and individuals worldwide, delivering information that hasn’t always been available to them. We will give them back a voice – a voice that’s empowering because it is theirs – and provide a platform to communicate between themselves and the world.

We believe people are not just generic demographics; they are individuals with their own preferences and curiosities. We are about understanding these individuals, listening to them, and serving them.

We are the new pioneering spirit of news – we’re not talking to everyone, we’re talking with every one.

If you want your news, your voice, your way, on your time – we’ve got news for you.




If you have any questions or concerns please email us on


  • Australia, Toll Free 1-800-983-421
  • Hong Kong, Toll Free 800-906-187
  • Singapore, Toll Free 800-852-3871
  • USA/Canada, Toll Free 1-800-830-4132

Advertise With Us

Interested in being awesome?
Contact us by email or phone.